Multicenter, Randomized, Open and Sequential Study to Evaluate the Efficacy and Safety of Bemiparin Administration on the Response to Treatment in Patients Diagnosed With Limited Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Bemiparin sodium (Primary) ; Carboplatin; Cisplatin; Etoposide
- Indications Embolism and thrombosis; Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms ABEL
- 07 Jun 2012 Additional lead trial investigator (Font A) added as reported by ClinicalTrials.gov.
- 05 Jun 2012 Final results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
- 21 Oct 2011 Final results were presented at the XIII National Congress of the Spanish Society of Medical Oncology, and also in a Laboratorios Farmaceuticos Rovi media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History